Kyverna Therapeutics's top three insider shareholders as of May 14, 2026 are Ventures, Llc Vida (TenPercentOwner, 4.78Mn shares), Fred E Cohen (Director, 4.52Mn shares), Sciences, Inc. Gilead (TenPercentOwner, 4.13Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Ventures, Llc Vida | - | 0 | 4,777,060 | 14 Feb, 2024 |
| Fred E Cohen | - | 0 | 4,523,924 | 14 Feb, 2024 |
| Sciences, Inc. Gilead | - | 4,126,119 | 0 | 13 Feb, 2024 |
| Ventures Iii Gp, Llc Northpond | - | 0 | 3,255,426 | 12 Feb, 2024 |
| Capital Life Sciences Investors, Llc Bain | - | 0 | 3,163,868 | 14 Feb, 2024 |
| Biopartners Opportunity Fund I, L.P. Westlake | - | 0 | 869,317 | 22 Dec, 2025 |
| Biopartners Fund I, L.P. Westlake | - | 0 | 735,984 | 14 Feb, 2024 |
| Christi Shaw | Executive Chairperson | 70,935 | 0 | 14 Jan, 2026 |
| Warner Weston Biddle | Chief Executive Officer | 58,000 | 0 | 17 Mar, 2026 |
| Ryan Alexander Jones | Chief Financial Officer | 55,950 | 0 | 15 Apr, 2025 |
| Karen Marie Walker | Chief Technology Officer | 22,636 | 0 | 17 Dec, 2025 |
| Naji Gehchan | - | 18,000 | 0 | 17 Mar, 2026 |
| Ian T Clark | - | 16,634 | 0 | 02 Jun, 2025 |
| Mert Aktar | - | 16,634 | 0 | 02 Jun, 2025 |
| Fred E Cohen | - | 16,634 | 0 | 02 Jun, 2025 |
| Sravan Kumar Emany | - | 11,006 | 0 | 26 Feb, 2026 |
| Andrew Craig Miller | - | 11,006 | 0 | 04 Mar, 2026 |
| Marc Grasso | Chief Financial Officer | 10,000 | 0 | 17 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 13 Mar, 2026 | Naji Gehchan | Common Stock | A | 18,000 | $0.00 | 18,000 | D | A |
| 13 Mar, 2026 | Marc Grasso | Common Stock | A | 10,000 | $0.00 | 10,000 | D | A |
| 13 Mar, 2026 | Warner Weston Biddle | Common Stock | A | 58,000 | $0.00 | 58,000 | D | A |
| 13 Mar, 2026 | Marc Grasso | Stock Option (right to buy) | A | 65,000 | $0.00 | 65,000 | D | A |
| 13 Mar, 2026 | Warner Weston Biddle | Stock Option (right to buy) | A | 350,000 | $0.00 | 350,000 | D | A |
| 13 Mar, 2026 | Naji Gehchan | Stock Option (right to buy) | A | 105,000 | $0.00 | 105,000 | D | A |
| 24 Feb, 2026 | Andrew Craig Miller | Common Stock | A | 11,006 | $0.00 | 11,006 | D | A |
| 24 Feb, 2026 | Andrew Craig Miller | Stock Option (right to buy) | A | 42,945 | $0.00 | 42,945 | D | A |
| 24 Feb, 2026 | Sravan Kumar Emany | Common Stock | A | 11,006 | $0.00 | 11,006 | D | A |
| 24 Feb, 2026 | Sravan Kumar Emany | Stock Option (right to buy) | A | 42,945 | $0.00 | 42,945 | D | A |
| 09 Feb, 2026 | Mayobanex Pujols | Stock Option (right to buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 12 Jan, 2026 | Christi Shaw | Common Stock | A | 30,000 | $0.00 | 46,634 | D | A |
| 12 Jan, 2026 | Christi Shaw | Common Stock | A | 24,301 | $0.00 | 70,935 | D | A |
| 12 Jan, 2026 | Christi Shaw | Stock Option (right to buy) | A | 185,000 | $0.00 | 185,000 | D | A |
| 18 Dec, 2025 | Biopartners Opportunity Fund I, L.P. Westlake | Common Stock | A | 133,333 | $7.50 | 869,317 | I | P |
| 15 Dec, 2025 | Karen Marie Walker | Common Stock | A | 23,998 | $4.83 | 46,634 | D | M |
| 15 Dec, 2025 | Karen Marie Walker | Common Stock | D | 23,998 | $12.20 | 22,636 | D | S |
| 15 Dec, 2025 | Karen Marie Walker | Stock option (right to buy) | D | 23,998 | $0.00 | 85,865 | D | M |
| 30 Jun, 2025 | Marc Grasso | Stock Option (right to buy) | D | 450,000 | $0.00 | 450,000 | D | A |
| 29 May, 2025 | Mert Aktar | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |